Central nervous system toxoplasmosis in adult ethiopians

Ethiopian Medical Journal

Volumn 44, Issue 2, 2006, Pages 113-120

  Amogne, Wondwossen ^a   Teshager, Getnet ^a   Zenebe, Guta ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; FANSIDAR; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; DRUG COMBINATION; ETHIOPIA; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SEX RATIO; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; DRUG COMBINATIONS; ETHIOPIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIMETHAMINE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SULFADOXINE; TOXOPLASMOSIS, CEREBRAL; TREATMENT OUTCOME;

EID: 33845774300     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992; 15: 211-22
2. Hard M Heller. Toxoplasmosis in HIV-infected patients In Up To Date 2004, Up to Date Inc, 34 Washington Street, Version 12(1)
3. Guebre-Xabier M, et al. Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia. Ethiop Med J. 1993 Jul; 31(3): 201-8
4. Woldemichael T, et al. Évaluation of Eiken latex agglutination test for Anti-Toxoplasmosis antibodies and seroprevalence of Toxoplasmosis infection among factory workers in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 1998 Jul-Aug; 92(4): 401-3
5. Lopez R, Contreras R, Font L, Vega O. Presence of antibodies against Toxoplasma gondii in adolescents from African continent. Rev Latino am Microbiol. 1992Jan-Mar; 34(1): 49-52.
6. th report, June 2004.
7. Henry W. Murray, Christine Katalma. Toxoplasmosis. In Raphael Dolin, Henry M, Michael S.S. eds. AIDS Therapy, Second edition. Churchill Livingstone, 2003: 419-37
8. Steven B. Porter and Merle A. Sande. Toxoplasmosis of the Central Nervous System in the Acquired Immuno deficiency Syndrome. N Engl J Med 1992; 327: 1643-8
9. Ciricillo SF, Rosenblum ML. Imaging of solitary lesions in AIDS. J Neuro surg 1991; 74: 1029
10. Dina TS. Primary central nervous system lymphoma versus Toxoplasmosis in AIDS. Radiology 1991; 179: 823-8
11. th ed. Philadelphia, WB Saunders, 1995, 460.
12. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in Patients with the acquired immunodeficiency syndrome. NEJM 329: 995, 1993.
13. Wong SY, Remington JS. Toxoplasmosis in the setting of AIDS. In: Broder S, Merigan TC, Bolognesi D (eds). Textbook of AIDS medicine. Baltimore, Williams & Willikins, 1994, 223
14. th edn. McGraw Hill. 2005, 1247
15. Paulic P, Pester P, Bonnet E, et al. Treatment of brain toxoplasmosis by Fansidar. Int Conf AIDS 1990, Jun 20-23; 6:241 (abstract no. Th.B.478)
16. Conn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empiric treatment of suspected toxoplasma Encephalitis in patients with acquired immunodeficiency syndrome. Am J Med 1989; 86:521-7
17. Wanke C, Tuazon CU, Kovacs A, et al. Toxoplasma encephalitis in Patients with acquired immunodeficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg 1987; 36:509-16
18. Leport C, Raffi F, Matheron S, et al. Treatment of central nervous System toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: efficacy of long-term continuous therapy. Am J Med 1988; 84:94-100